Related Experiment Videos
Venous thrombosis after long-haul flights
Thomas Schwarz1, Gabriele Siegert, Wolfram Oettler
1Division of Vascular Medicine, Department of Internal Medicine III, University of Dresden Medical School, Germany. tho_schwartz@hotmail.com
Archives of Internal Medicine
|December 10, 2003
Summary
Long-haul flights of 8 hours or more double the risk of developing calf muscle venous thrombosis. This increased risk for venous thromboembolism was primarily observed in passengers with pre-existing risk factors.
Area of Science:
- Vascular Medicine
- Public Health
- Epidemiology
Background:
- The association between long-haul flights and venous thromboembolism (VTE) is a debated topic.
- Assessing the incidence of flight-associated thrombosis is crucial for understanding travel-related health risks.
Purpose of the Study:
- To prospectively evaluate the incidence of venous thrombosis in passengers undertaking long-haul flights.
- To compare thrombosis rates between long-haul travelers and a non-traveling control group.
Main Methods:
- A prospective, controlled cohort study involving 964 long-haul flight passengers (≥8 hours) and 1213 controls.
- Exclusion criteria included anticoagulant use and compression stocking use.
- Outcomes measured: ultrasonographically diagnosed calf muscle and deep vein thrombosis, symptomatic pulmonary embolism, and death.
Main Results:
- Venous thrombotic events occurred in 2.8% of passengers versus 1.0% of controls (Risk Ratio [RR], 2.83).
- Isolated calf muscle venous thrombosis was diagnosed in 2.1% of passengers and 0.8% of controls (RR, 2.52).
- Deep venous thrombosis occurred in 0.7% of passengers and 0.2% of controls (RR, 4.40); all cases had pre-existing risk factors.
Conclusions:
- Flights of 8 hours or longer significantly increase the risk of isolated calf muscle venous thrombosis.
- This elevated risk extends to deep venous thrombosis, particularly in individuals with established risk factors.
- Flight-associated thrombosis was exclusively identified in passengers with known risk factors for venous thrombosis.